Last updated: March 31, 2023
Sponsor: Maastricht University Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lung Disease
Non-small Cell Lung Cancer
Lung Cancer
Treatment
N/AClinical Study ID
NCT05794529
METCZ20220060
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Aged 18-65 years
- Compos mentis
- Diagnosed with lung cancer, with treatment requiring a thoracotomy or VATS lobectomy
Exclusion
Exclusion Criteria:
- Neoadjuvant chemo- or radiotherapy in the past four weeks
- Use of systemic steroids in the past four week
- Insulin-dependent diabetes mellitus
- Pregnancy
Study Design
Total Participants: 30
Study Start date:
March 01, 2023
Estimated Completion Date:
March 31, 2026
Connect with a study center
Zuyderland Medical Center
Heerlen, Limburg 6419 PC
NetherlandsActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.